Gravisafe Tablets: First-Line Therapy for Ovulation Induction & Fertility Support

Product Range: Dydrobest (Gynaecology Division) Format: Film-Coated Tablets

Product Information

Brand Name: Gravisafe Tablets Composition: Letrozole 2.5 mg

Overview

Gravisafe Tablets serve as a highly effective, first-line therapeutic option for ovulation induction in female infertility. Originally recognized as a potent aromatase inhibitor, Gynaecologists and fertility specialists now utilize Letrozole as the superior standard of care for helping women conceive, particularly those managing Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly Polycystic Ovarian Syndrome (PCOS). Gravisafe offers a significant clinical advantage over older fertility drugs by producing higher ovulation and pregnancy rates while maintaining an optimal uterine environment for successful embryo implantation.

Mechanism of Action: Targeted Hormonal Stimulation

Gravisafe operates as a highly specific, reversible aromatase inhibitor. It works by temporarily blocking the aromatase enzyme, which prevents the body from converting androgens into estrogens. This temporary drop in systemic estrogen levels removes the negative feedback on the brain’s pituitary gland. In response, the pituitary gland actively secretes more Follicle Stimulating Hormone (FSH). This targeted surge in FSH directly stimulates the ovaries, prompting the healthy growth, maturation, and release of one or more follicles (eggs).

Key Benefits & Uses:

• Superior Implantation Environment: Unlike older fertility medications (such as Clomiphene) that can thin the uterine lining, Gravisafe preserves optimal endometrial thickness and cervical mucus quality, drastically improving the chances of successful embryo implantation.
• Higher Ovulation Rates in PMOS: Actively induces ovulation in women with PMOS who have previously failed to respond to other fertility treatments.
• Reduced Risk of Multiples: Primarily promotes mono-follicular development (the release of a single egg), which significantly lowers the high-risk complication of multiple pregnancies (twins or triplets).
• Rapid Clearance: Features a short half-life, meaning the medication clears the body quickly and safely before the embryo implants.
• Better Patient Tolerance: Minimizes the uncomfortable side effects typically associated with estrogen-receptor blockers, such as severe hot flashes or mood swings.

Indications

• Anovulatory Infertility (failure to ovulate)
• PMOS related infertility
• Unexplained Infertility
• Ovulation induction prior to Assisted Reproductive Technology (ART) or Intrauterine Insemination (IUI) procedures

Dosage & Administration

• Standard Protocol: Typically, the patient takes one tablet (2.5 mg) daily for five consecutive days, starting on day 3, 4, or 5 of the menstrual cycle.
• Administration: Swallow the tablet whole with a glass of water, with or without food.
• Strictly follow the precise cycle days and dosage as prescribed by the treating Gynaecologist or Fertility Specialist.

⚠️ DISCLAIMER: Gravisafe Tablets are a strict prescription-only pharmaceutical formulation. Patients must use this medication exclusively under the direct supervision, follicular monitoring, and guidance of a registered Gynaecologist or fertility expert. Do not self-medicate.

Business Partnership Opportunity

Command the Fertility & Gynaecology Market with Best Biotech

Are you an ambitious pharmaceutical distributor looking to dominate the rapidly expanding fertility and women’s health sector? The Dydrobest Division of Best Biotech invites driven professionals to join our network through our Pharma PCD and Franchise distribution models. Infertility management is one of the most critical and high-value therapeutic segments in healthcare today. By equipping your portfolio with top-tier, highly prescribed fertility solutions like Gravisafe Tablets, you ensure sustained business growth, high physician trust, and consistent repeat demand from Gynaecology and IVF clinics.

Why Partner with Best Biotech?

• Exclusive Monopoly Rights: Secure uncompromised distribution rights for your specific territory.
• Unmatched Quality Assurance: We manufacture all formulations in state-of-the-art, ISO-certified facilities to ensure maximum clinical efficacy.
• Powerful Marketing Arsenal: We empower our partners with premium pharma visual aids, scientific detailing materials, and reliable supply chain support.

Connect with our Franchise Development Team today to lock in your territory, request our complete Dydrobest price list, and build a highly profitable, purpose-driven pharmaceutical business.

Related Products:

1. BENFIT-M-SR TABLETS: Dosage, Uses & Product Information
2. BENFIT-M TABLETS: Dosage, Uses & Product Information
3. TASTIRON-XT SYRUP: Dosage, Uses & Product Information
4. BENFIT-M SACHETS
5. BENFIT-M SYRUP

Quick Links:

1. Can Less ‘Sun-Time’ Drive High Blood Pressure?
2. Why Your Acid Reflux is Not Improving With Medicines? What Can Be Done?
3. “India’s AQI is Redlining: Protecting Your Lungs with Science, Strategy, and Immunity”
4. Best Biotech India – PCD Pharma Franchise in Assam
5. Pharma Franchise & PCD Opportunity: Market WIKLYONE, the Future of Diabetes Management